Naba Alsaha Medical Services Co. vs Mouwasat Medical Services Co.
A head-to-head of Naba Alsaha Medical Services Co. (9546) and Mouwasat Medical Services Co. (4002) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
Naba Alsaha Medical Services Co.
9546
21.38 SAR
0.00%
VS
Mouwasat Medical Services Co.
4002
60.90 SAR
+0.25%
| Metric | 9546 | 4002 |
|---|---|---|
| Market Cap | 462.00M SAR | 12.18B SAR |
| P/E (TTM) | 8.16 | 14.82 |
| Forward P/E | — | 13.87 |
| P/S | 2.29 | 4.02 |
| P/B | 2.02 | 3.06 |
| EV/EBITDA | 13.43 | 12.54 |
| Dividend Yield | 70.00% | 6.24% |
| Profit Margin | 13.64% | 25.09% |
| Gross Margin | 32.80% | 42.25% |
| Operating Margin | 15.26% | 26.98% |
| Revenue Growth (YoY) | +5.80% | +9.09% |
| FCF Yield | — | 5.10% |
| Debt / Equity | 54.27 | 28.00 |
| Current Ratio | 6.26 | 1.62 |
Which is better: Naba Alsaha Medical Services Co. or Mouwasat Medical Services Co.?
- ✓Larger by market cap: Mouwasat Medical Services Co.
- ✓Cheaper valuation (lower P/E): Naba Alsaha Medical Services Co.
- ✓Higher dividend yield: Naba Alsaha Medical Services Co.
- ✓More profitable (net margin): Mouwasat Medical Services Co.
- ✓Faster revenue growth: Mouwasat Medical Services Co.
Across 11 available metrics, Mouwasat Medical Services Co. leads 6–5.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
Compare Naba Alsaha Medical Services Co. with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.